CorMedix

Recent news

• Analysts Are Bullish on Top Healthcare Stocks: Parabilis Medicines, Inc. (PBLS), Cormedix (CRMD)
  TipRanks · 2026/8/14
• Rating change
  Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating
  Market Newswire · 2026/5/15
• Rating change
  RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $22
  Market Newswire · 2025/11/13
• Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $15
  Market Newswire · 2026/8/14
• Rating change
  H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $18
  Market Newswire · 2026/1/10
• Rating change
  Analysts' Top Healthcare Picks: Cormedix (CRMD), CG Oncology, Inc. (CGON)
  TipRanks · 2026/2/4
• Rating change
  Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $16
  Market Newswire · 2026/1/9
• RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $13
  Market Newswire · 2026/7/7
• Rating change
  RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13
  Market Newswire · 2026/4/9
• Rating change
  Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $16
  Market Newswire · 2025/12/19
• Rating change
  H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $13
  Market Newswire · 2026/1/23
• Rating change
  H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $18
  Market Newswire · 2025/11/13
• Rating change
  Needham Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $15
  Market Newswire · 2026/1/9
• Rating change
  Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating, Announces Target Price $16
  Market Newswire · 2026/1/9
• Rating change
  Needham Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $14
  Market Newswire · 2026/3/6
• Rating change
  Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $14
  Market Newswire · 2026/4/15
• H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13
  Market Newswire · 2026/8/14
• Rating change
  A Quick Look at Today's Ratings for CorMedix(CRMD.US), With a Forecast Between $13 to $15
  Market Newswire · 2026/5/15
• Rating change
  Leerink Partners Maintains CorMedix(CRMD.US) With Buy Rating, Announces Target Price $13
  Market Newswire · 2026/3/7
• RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $14
  Market Newswire · 2026/8/14

Headlines are aggregated automatically and are not independently verified or edited by our team.